Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib

Yoshihiro Fujimura(Japanese Red Cross Society, Japan), Hiroshi Fukui(Nara Medical University), Yoshiko Usami(University of Massachusetts Chan Medical School), Koiti Titani(Gifu Pharmaceutical University), Kenji Nishio(Fujita Health University), A. Yoshioka(Gifu Pharmaceutical University), K. Niinomi(Nara Medical University), T Takase(Nara Medical University)
Cited by 2


Related Papers